Ligand Pharmaceuticals, Inc.
(NASDAQ : LGND)

( )
LGND PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corp.
0.10%108.241.3%$1555.46m
BIIBBiogen, Inc.
-0.01%285.401.4%$826.42m
AMGNAmgen, Inc.
0.45%225.511.3%$560.39m
GILDGilead Sciences, Inc.
-0.19%64.881.0%$407.05m
VRTXVertex Pharmaceuticals, Inc.
0.03%215.071.9%$345.44m
ILMNIllumina, Inc.
1.25%314.913.5%$336.38m
REGNRegeneron Pharmaceuticals, Inc.
-0.06%344.242.6%$279.87m
EXASEXACT Sciences Corp.
0.16%83.9324.0%$220.79m
ALXNAlexion Pharmaceuticals, Inc.
-1.92%108.532.0%$184.76m
BMRNBioMarin Pharmaceutical, Inc.
-0.39%77.434.3%$134.14m
SRPTSarepta Therapeutics, Inc.
4.35%102.3014.6%$126.57m
SGENSeattle Genetics, Inc.
2.51%120.846.1%$125.11m
AAgilent Technologies, Inc.
-1.00%78.501.6%$103.06m
BGNEBeiGene Ltd.
-0.29%203.312.1%$94.15m
NBIXNeurocrine Biosciences, Inc.
0.31%113.085.0%$92.24m

Company Profile

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.